Biotech

All Articles

Galapagos stops CAR-T cell treatment litigation over Parkinsonism scenario

.Galapagos has paused registration in a test of a BCMA-directed CAR-T cell treatment, pushing the br...

James Wilson leaving behind Penn to launch two new biotechs

.After greater than 30 years, genetics therapy trailblazer James Wilson M.D., Ph.D., is actually lea...

3 biotechs make an effort to defeat the summer season heat by shedding workers

.As biotechs attempt to transform a new page in August, at the very least three providers have shed ...

venBio lifts $528M for fifth lifestyle scientific researches VC fund

.Veteran financial backing firm venBio has actually lifted another half a billion dollars to invest ...

Otsuka pays out $800M for Jnana and also its clinical-stage PKU medicine

.Otsuka Pharmaceutical has actually grabbed Boston-based Jnana Rehabs for $800 million so the Easter...

FibroGen lays off 75% people workers as asset flunks 2 more trials

.FibroGen is substantially reorganizing its organization, laying off 75% of its U.S. team and stoppi...

Tracon wane weeks after injectable PD-L1 prevention fail

.Tracon Pharmaceuticals has chosen to wane operations weeks after an injectable invulnerable gate pr...

Ideaya bags choice on Biocytogen bispecific ADC in $400M bargain

.Ideaya Biosciences is betting $400 million in biobucks that a bispecific antibody-drug conjugate (A...

Takeda takes $140M reduction on fallen short epilepsy drug, promotes FDA operate

.We presently recognize that Takeda is actually expecting to discover a road to the FDA for epilepsy...

VBI Vaccinations declare bankruptcy, finds possession purchase

.Immunology biotech VBI Vaccinations is veering dangerously near the moment of truth, along with str...